熱門資訊> 正文

BioNTech首席战略官辞职

2025-07-17 23:40

BioNTech (NASDAQ:BNTX) Chief Strategy Officer Ryan Richardson will leave that position on Sept. 30 to pursue another opportunity.
He will also resign as a board member of BioNTech affiliated companies.
Richardson joined the German biotech in 2018 and became chief strategy officer in January 2020.
During his tenure, he oversaw BioNTech's Series B financing, IPO, and follow-on equity financings.

More on BioNTech

BioNTech: More Uncertainty Emerges
BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer
Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment
Pfizer, BioNTech challenge Moderna’s COVID vaccine patent win in U.K.
RFK Jr. sued by doctor, health groups over changes to COVID shot recommendations

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。